Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.37 USD | 0.00% | -0.04% | +57.28% |
05-01 | North American Morning Briefing : Traders Wait for -2- | DJ |
04-30 | Barclays Upgrades Deciphera Pharmaceuticals to Equalweight From Underweight, Price Target is $26 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+57.28% | 2.09B | |
+2.97% | 108B | |
+10.21% | 104B | |
+2.50% | 22.33B | |
-12.77% | 22.19B | |
-7.05% | 18.69B | |
-37.64% | 17.74B | |
-6.50% | 17.64B | |
+6.00% | 14.05B | |
+37.20% | 12.51B |
- Stock Market
- Equities
- DCPH Stock
- News Deciphera Pharmaceuticals, Inc.
- Deciphera Pharmaceuticals' Q3 Net Loss Widens, Revenue Rises; Says Phase 3 Tumor Drug Trial Met Primary Endpoint